Iron is an essential nutrient that may exert toxic effects when it accumulates in tissues. Little is known regarding its effects on gonadal function. Both Fe 2+ and Fe 3+ could be released from iron deposition. We employed mouse nonluteinized granulosa cell for in vitro studies and human ovarian tissues for Prussian blue and immunohistochemical staining to identify the iron deposition and effect in vivo. After treatment with FeSO 4 -7H 2 O or FeCl 3 in granulosa cell cultured with folliclestimulating hormone (FSH) for 48 h, we found that Fe 2+ significantly suppressed FSH-induced granulosa cell proliferation and arrested the cell cycle at the G2/M phase by cell proliferation assay and flow cytometry. Fe 2+ significantly increased intracellular reactive oxygen species (ROS) and ferritin levels of mouse granulosa cells. The increases in p21 and p53 messenger RNA and protein expression facilitated by Fe 2+ treatment in mouse granulosa cells were significantly suppressed by separate treatments with p53 small interfering RNA and p38 mitogen-activated protein kinase (MAPK) inhibitors. An ROS inhibitor downregulated Fe 2+ -induced increases in p38MAPK expression in mouse granulosa cells. Quantitative analysis of immunohistochemical staining revealed that human ovarian tissue sections with positive Prussian blue staining had lower levels of proliferating cell nuclear antigen expression, but higher levels of p21, p53, and CDC25C expression than those with negative Prussian blue staining. Conclusively, Fe 2+ could directly arrest the cell cycle and inhibit granulosa cell proliferation by regulating the ROS-mediated p38MAPK/p53/p21 pathway. Therefore, iron can directly affect female gonadal function. The effect of iron on ovarian granulosa cells, 2017, Vol. 97, No. 3 
Introduction
Iron is an essential nutrient that plays a role in numerous vital mammalian physiologic processes; however, iron exerts toxic effects when it accumulates in tissues, as it catalyzes the generation of free radicals, resulting in cellular dysfunction. Iron accumulation in tissues is believed to be involved in human aging and an increased risk of chronic diseases such as diabetes, atherosclerosis, hypertension, and insulin resistance-related metabolic disorders [1] [2] [3] . Although iron levels have been detected in follicular fluid and negatively associated with the ovarian reserve in women with endometriosis [4] ; however, there is still little information regarding the effects of iron on reproductive and gonadal function.
Primary iron overload mainly affects patients with hereditary hemochromatosis and β-thalassemia major, who require frequent blood transfusions. However, iron levels can also increase in certain chronic metabolic diseases such as diabetes, hypertension, and obesity. Insulin stimulates iron entry into cells by facilitating transferrin receptor redistribution, which results in increased intracellular iron levels including ferrous iron (Fe 2+ ) and ferritin depots containing ferric iron (Fe 3+ ) [5] . Decreased antioxidant levels leading to an increase in oxidative stress in the human body may trigger rapid iron release from ferritin deposits, resulting in intracellular iron accumulation [3, 5] . Therefore, iron overload can be acquired and exert its destructive effects on various target tissues in response to oxidative stress [3, 6, 7] . It is well known that iron deposition tends to occur in various organs and tissues; however, there are only a few clinical reports that have suggested that iron overload has adverse effects on reproductive function [8, 9] ; furthermore, little is known regarding the direct effect of iron on the gonads [10] . Ferric and ferrous iron have been shown to accumulate in aged mouse ovaries [11] , healthy bovine ovaries [12] , and ovaries of a woman with thalassemia major [13] . Clinical studies have found indirect evidence of gonadal dysfunction characterized by decreased ovarian volumes and anti-Müllerian hormone (AMH) levels in women with β-thalassemia major caused by chronic iron overload secondary to repeated blood transfusions [9, 14, 15] . These studies suggested that iron exerts destructive effects on the granulosa cells of ovarian follicles. Furthermore, there is increasing evidence that accumulation of reactive oxygen species (ROS) is associated with declines in ovarian function due to oocyte aging and granulosa cell dysfunction [11, 16, 17] . However, if the iron exerted its inhibitory effect on the ovarian granulosa cells proliferation through regulating cell cycle arrest has not been reported previously.
In this study, we hypothesized that the deposited iron on the ovary might directly destroy the ovarian granulosa cell proliferation. We investigated factors that might be involved in the iron-related gonadal damage by performing in vitro studies of mouse nonluteinized granulosa cells and in vivo immunohistochemical staining of human ovarian tissue samples.
Materials and Methods

Mice granulosa cell isolation and culture
For the experiments involving mice, all the animal care procedures and experiments were performed according to the Assessment and Accreditation of Laboratory Animal Care-approved guidelines using protocols approved by the Institutional Review Board-Institutional Animal Care and Use Committee of National Taiwan University Hospital. Granulosa cells were isolated from freshly removed ovaries of 6-week-old Institute of Cancer Research (ICR) mice sacrificed 48 h after 5 IU pregnant mare's serum gonadotropin (PMSG, SigmaAldrich, St. Louis, Missouri, USA) injection at the time of the estrus phase according to a previous reference [18] and cultured without prior treatment. Use of PMSG but without Human Chorionic Gonadotropin (HCG) induced a superovulation mice model, which mainly caused preovulatory follicle accumulation in order to retrieve large number of nonlutenizing granulosa cells for experiments. Moreover, the purity of these isolated granulosa cells was confirmed by immunostaining for Follicle Stimulating Hormone Receptor (FSHR), and the cells were quantified by flow cytometry before being used for subsequent in vitro experiments. The granulosa cell isolation and culture methods were described in our previous study [19] . Briefly, ovaries were incubated in cold serum-free medium consisting of 15 mM hydroxyethyl piperazineethanesulfonic acid (HEPES) (pH 7.4), Dulbecco modified Eagle's medium (DMEM)/F-12, human insulin (2 μg/ml), hydrocortisone (40 ng/ml), and antibiotics. After being incubated in medium containing 0.5 M sucrose and 10 mM ethylene glyco tetraacetic acid (EGTA) at 37
• C for 30 min, the ovaries were washed with fresh DMEM/F-12, and granulosa cells were removed from the ovaries via follicular puncture with a 25-gauge hypodermic needle. The cells were subsequently incubated in DMEM/F12 medium supplemented with 10% fetal bovine serum (FBS) (Gibco BRL, Grand Island, NY, USA) under a humidified atmosphere of 5% CO 2 at 37
• C. The granulosa cells retrieved from ovaries of five mice were pooled together to avoid individual variation before subdivided and cultured for different in vitro experiments.
Proliferation evaluation by 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
To study the cell proliferation in response to the iron treatment, mouse ovarian granulosa cells were cultured with or without FSH (10 ng/ml), and treated with 500 μM Fe 2+ (or Fe 3+ ) concentrations for 24 h, 3 days, and 5 days as indicated. Mouse granulosa cells were granulosa cells that were seeded into 96-well microplates at a density of 1 × 10 3 cells/well for a cell proliferation assay. Briefly, the cells were cultured at 37
• C for the indicated time, and 30 μl of MTT solution (5 mg/ml) was added to each well. Then, the cells were incubated for 4 h in the dark. The resulting formazan crystals were subsequently dissolved in Dimethyl Sulfoxide (DMSO), and the absorbance was measured at 570 nm using an enzyme-linked immunosorbent assay (ELISA) plate reader.
Antibodies and reagents
Antibodies against p-p38 (sc-7973, dilution used 1:1000 for western blot), p38 (sc-535, dilution used 1:1000 for western blot), p21 (sc-271532, dilution used 1:1000 for western blot and 1:100 for immunohistochemistry [IHC]), p53 (sc-393031, dilution used 1:1000 for western blot and 1:100 for IHC), CDC25C (sc-5620, dilution used 1:100 for IHC), proliferating cell nuclear antigen (PCNA, sc proteins were determined by western blotting. In vitro culture for each treatment of all experiments was replicated at least three times. Granulosa cells (1 × 10 6 cells/well) were cultured in 6-well plates.
The cells were lysed using lysis buffer (the same as cellular ferritin level detection) and centrifuged at 12 000 rpm for 25 min at 4
• C.
The cell lysates were purified and quantified using a Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA). A total of 50 μg of protein was separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) before being transferred onto a polyvinylidene difluoride membrane and immunoblotted with various antibodies. Bound antibodies were detected using the appropriate peroxidase-coupled secondary antibodies and an enhanced chemiluminescence detection system (Boehringer Mannheim, Indianapolis, IN, USA). Target immunoreactive proteins on the membranes were visualized using the MultiGel-21 Image system (TOP BIO CO. Taipei, Taiwan). The relative intensities of the expression of specific proteins (bands) were further analyzed using ImageJ software.
RNA interference
An siRNA duplex with sequences specific for the p53 gene (sc-29436) and a negative control siRNA (sc-37007) sequence with no similarity to any gene product were purchased from Santa Cruz Biotechnology. Lyophilized siRNA duplexes were resuspended in RNase-free water at a concentration of 10 mM with 10 mM Tris-HCl, pH 8.0, 20 mM NaCl, and 1 mM EDTA buffered solution. The siRNAs were incubated for 15 min at room temperature to allow the formation of complexes between the siRNAs and TransFast Transfection Reagent Real-time reverse transcriptase polymerase chain reaction
Granulosa cells were cultured with 500 μM Fe 2+ (or Fe 3+ ) for indicated time period to test the mRNA levels of p21 and p53, and 8 h to test p21 mRNA for siRNA experiments. The expression levels of mouse p21 and p53 mRNA were quantified using a fluorescein quantitative real-time PCR detection system (Light Cycler DNA master SYBR Green I; Roche Molecular Biochemicals, Indianapolis, IN, USA). The primer pairs were 5 -TTG CAC TCT GGT GTC TGA GC-3 and 5 -TCT CGC CTT GGA GTG ATA GA-3 for p21, 5 -AAC CGC CGA CCT ATC CTT AC-3 and 5 -CTT CTG TAC GGC GGT CTC TC-3 for p53, and 5 -TGT GTC CGT CGT GGA TCT GA-3 and 5 -TTG CTG TTG AAG TCG CAG GAG-3 for GAPDH. A melting curve analysis was performed following amplification to verify the correctness of the amplicons. We measured the levels of p21 and p53 mRNA expression using GAPDH mRNA as an internal control. The unit used for measuring mRNA expression levels was an arbitrary unit equivalent to the amount of mRNA at time zero or in cells treated with vehicle controls. The Quantitative real time polymerase chain reaction (qPCR) products of mouse p21 (598 bp), p53 (439 bp), and GAPDH (233 bp) were sequenced and analyzed by alignment statistics for a match by GenBankGraphics to confirm that the specific reactions were for mouse p21, p53, and GAPDH, respectively.
Human ovarian tissue collection
A total of 24 women (mean age 46.8 ± 9.7 years old, range 28-62 years old) with histologically confirmed diagnoses of endometrioid adenocarcinoma with tumors confined within the uterus (endometrial cancer stages I-II) without ovarian involvement were enrolled in this study (Supplementary Table S1 ). Since bilateral oophorectomy is the standard procedure of endometrial cancer staging surgery, therefore, both ovaries from each patient could be excised and sectioned for experimentation to avoid selection bias. All the excised ovaries were grossly normal and histologically confirmed to be without pathology. None of the enrolled subjects had histories of blood transfusion or blood product therapy or of other major medical diseases, with the exception of diabetes and/or hypertension. The Research Ethics Committee of National Taiwan University Hospital had approved the protocol for all experiments and the informed consent used in the present study. All experiments pertaining to the human studies in the methods section were performed in accordance with the relevant guidelines and regulations, and were proved by the Research Ethics Committee of National Taiwan University Hospital (NTUH-REC No: 201306062RIND). Informed consent was obtained from each subject enrolled in this study. Ovarian tissue samples were fixed in formalin and embedded in paraffin. Two to four paraffin blocks were obtained from each ovary, depending on the size of the ovary. Sections from each ovarian paraffin-embedded block were taken at a thickness of 4-6 μm and mounted on a glass slide for subsequent Prussian blue staining and immunohistochemical staining. IHC and Prussian blue staining results were evaluated by two observers who were blinded to the origins of the sections, using a conventional light microscope.
Prussian blue staining
Prussian blue stains hemosiderin and ferritin deposits, and can be used to measure iron deposition [20] . The stain consists of equal quantities of 20% hydrochloric acid and 10% potassium ferricyanide (Sigma, St Louis, MO, USA). Before dehydration, glassmounted sections were stained with Prussian blue for 20 min, washed with running water for 1 min, and then counterstained with 0.5% aqueous nuclear fast red solution (Sigma) for 1 min. Prussian blue staining was assessed under low magnification (40×) to confirm the presence of iron deposits. One slide per paraffin-embedded block and 2-4 slides per ovary were stained with Prussian blue. Positive Prussian blue staining of a slide was defined as visible blue-colored granules around one or more antral follicles. Among a total of 24 enrolled subjects, 19 subjects who both ovarian tissue block with and without positive Prussian blue staining were subjected to paired IHC staining and analysis to avoid individual variation. After Prussian blue staining had been done, the selected ovarian tissue blocks were then sectioned for subsequent IHC staining. The other five enrolled subjects with ovarian tissue blocks exhibiting all negative Prussian blue staining were not subjected to IHC staining and analysis. The demographic data of all enrolled subjects for Prussian blue staining but with or without ovarian iron deposition was shown in Supplementary Table S1 .
Immunohistochemistry
Ovarian cross sections were deparaffinized, rehydrated, and microwaved in 0.01 M citrate buffer (pH 6.0) for antigen retrieval. The sections were then blocked with normal serum and incubated with various antibodies, including p21 (sc-271532), p53 (sc-393031), CDC25C (sc-5620), and PCNA (sc-56), as indicated. Immunoreactivity was visualized using an ABC staining system (Vector Laboratories, Burlington, CA, USA), according to the manufacturer's instructions. The sections were counterstained with Mayer hematoxylin. The percentage of granulosa cells with positive staining was determined by a total of 1000 granulosa cells in a large follicle via microscopy at 400× magnification in each slide. Nineteen slides with and without positive Prussian blue staining were calculated and averaged in each group.
Statistical analysis
Data are presented as the mean ± standard deviation (SD) or mean ± standard error of mean (SEM) as indicated. All the cell-based experiments that repeated for at least three times under same experimental condition, the quantitative results were pooled for statistical analysis. The Student t-test or Mann-Whitney U-test for two groups analysis, and Kruskal-Wallis test or one-way analysis of variance with post hoc analysis were used for multiple comparisons. All statistical analyses were performed using the Statistical Analysis System (SAS version 9.3; SAS Institute Inc., Cary, NC, USA). P values less than 0.05 were considered statistically significant. Figure 1A ) and Fe
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( Figure 1B ) in comparison to the vehicle treatment group. The ferritin levels of granulosa cells were significantly reduced when using Based on the observation of Fe 2+ treatment caused by G2/M phase arrest in granulosa cells, we therefore determined the expression of p21, also known as cyclin-dependent kinase (CDK)-interacting protein 1, which is a universal inhibitor of cyclin kinase [21] and is involved in cell cycle arrest at G2/M phase [22, 23] . We therefore determined the effects of Fe 2+ and Fe 3+ on p21 protein expression.
Western blotting (Figure 2A and B) and related quantitative analysis ( Figure 2C ) demonstrated that Fe 2+ , but not Fe 3+ , significantly increased the level of p21 protein expression in mouse granulosa cells in a dose-dependent manner. A time-course study showed that p21 mRNA expression increased significantly after 4 h of Fe 2+ treatment and peaked after 8 h of treatment compared to baseline and vehicle, while no changes in p21 mRNA expression were noted following Fe 3+ treatment, as shown in Figure 2D .
It is well known that p21 expression is regulated by the tumor suppressor protein p53 to control cell cycle [23] . To clarify the role of p53 in Fe 2+ -induced p21 expression, p53-specific siRNA was used to inhibit p53 expression. As expected, the p21 mRNA expression enhancement induced by Fe 2+ treatment in granulosa cell culture was significantly inhibited by p53 siRNA treatment, as shown in Figure  2E . The protein expression levels of p53 and p21 were significantly decreased by p53 siRNA treatment, as shown in Figure 2F . These findings demonstrated that p53 expression is critically involved in the Fe 2+ -induced increases in p21 expression in granulosa cells.
Iron may act through the p53-p38 mitogen-activated protein kinase signaling pathway and reactive oxygen species to suppress granulosa cell proliferation
The effect of Fe 2+ on ovarian dysfunction was supposed to be attributed from ROS. We then determined the generation of ROS in Figure 3B . By using fluorescence microscope to assess DCFDA fluorescence that represented the intracellular ROS generation as shown in Figure 3C , we found that the DCFDA fluorescence induced by 500 μM Fe 2+ treatment could be inhibited by cotreatment with an ROS inhibitor-NAC or an iron chelating agent-DFO. The time course of the effects of Fe 2+ treatment on p53 mRNA and protein expression is shown in Figure 4A and B. Compared to baseline and vehicle-treated group, both p53 mRNA expression and p53 protein expression levels significantly increased after 2 h of Fe 2+ treatment. p53 expression may be regulated by the phosphatidylinositol 3-kinase (PI3K) signaling pathway, the extracellularsignal-regulated kinase (ERK) signaling pathway, or the p38 mitogen-activated protein kinase (MAPK) signaling pathway. We used specific inhibitors to determine which signaling pathway is involved in Fe 2+ -mediated p53 expression. As shown in Figure 4C , neither the PI3K inhibitor (LY294002) nor the ERK-1/2 inhibitor (PD98059) affected p53 levels after Fe 2+ treatment. However, the p38 MAPK inhibitor (SB203580) significantly inhibited the increases in p53 expression facilitated by Fe 2+ treatment. Furthermore, p38
phosphorylation (p-p38) increased significantly after 1 h of Fe 2+ treatment ( Figure 4D ). These findings indicate that Fe 2+ treatment affects p38 MAPK pathway activity and therefore affects downstream p53 expression. ROS was supposed to be involved in the effect of Fe 2+ -treatment on p38 MAPK activation. NAC is commonly used to identify and test ROS inducers and to inhibit ROS [24] . We determined the effects of ROS on Fe 2+ -mediated enhancements of p38 phosphorylation. As shown in Figure 4E , the increases in p38 phosphorylation facilitated by Fe 2+ treatment in mouse granulosa cells were significantly reversed by p38 MAPK inhibitor (SB203580) or ROS inhibitor (NAC) administration. As for the effects of Fe 2+ and ROS for the cell cycle as shown in Figure 4F indicate that Fe 2+ like another ROS inducer, H 2 O 2 , significantly arrested the cell cycles at G2/M phase comparing to the control treatment, while NAC pretreatment significantly rescued both Fe 2+ -and H 2 O 2 -induced G2/M cell cycle arrest of mouse granulosa cells. The above results suggested that ROS plays an important role to suppress granulosa cell proliferation.
The relationship between granulosa cell proliferation, G2/M cell cycle arrest, and p21 and p53 expression in relation to iron deposition on human ovaries
In this study, we observed that iron deposition mainly occurred in the ovarian cortex and was preferentially located in the large antral follicles or corpus luteum. The Prussian blue-colored granules were visible in the cytoplasm of granulosa cells, theca cells, and interstitial macrophages. To determine the effects of ovarian iron deposition on p21 and p53 expression and granulosa cell proliferation, we compared the expression levels of p21, p53, CDC25C (a marker for cell cycle arrest at G2/M phase), and PCNA, a marker of cell proliferation, in the granulosa cells of large antral follicles from paired human ovarian sections with and without positive Prussian blue staining (paired sections from a total of 19 patients) by IHC staining. The representative corresponding Prussian blue staining images and immunohistochemical staining images, which are shown in Figure 5A , demonstrate p21, p53, CDC25C, and PCNA nuclear staining. The quantitative IHC results are shown in Figure 5B and reveal that p53, p21, and CDC25C expression levels were significantly increased, while PCNA levels were significantly decreased, in the granulosa cells of large antral follicles from ovarian tissue sections exhibiting positive Prussian blue staining (indicating iron deposition) compared with those exhibiting negative Prussian blue staining. These results indicate that iron deposition in the human ovary is associated with the increased expression of p21, p53, and CDC25C, but decreased expression of PCNA. These findings are in accordance with the results of in vitro studies and reveal that Fe 2+ -related cell cycle arrest might occur through ROS production and subsequent p38-MAPK/p53/p21 signaling pathway activity, leading to the suppression of granulosa cell proliferation (schematic diagram was shown in Figure 6 ).
Discussion
Iron is thought to be involved in the development of ovarian folliculogenesis, as evidenced by the presence of transferrin receptor and transferrin production in ovarian granulosa cells [11, 25] . Ovarian follicular ferritin and ferrous iron levels have been detected in follicular fluid during oocyte retrieval and negatively associated with the ovarian reserve [4] . Iron functions as a key player in oxidativereduction reaction in biology to generate reactive hydroxyl radicals and ROS. However, despite the clinical concerns about the chronic health effects in relationship to the iron load in women [1, 3] , and the inverse association between ovarian reserve and circulating ferritin levels in women with and without iron overload syndrome [15, 26] , there is still limited data regarding the effects of iron on the ovaries. Both ferrous and ferric iron (Fe 2+ and Fe 3+ ) were presented in the body, and could be released, stored, and regulated by the ferritin and hemosiderin complexes that were stained by the Prussian blue in response to the environmental oxidative stress and antioxidant levels [3, 27] . [28]. In addition, ferric iron and ferrous iron can be interconverted by ferrireductase and ferroxidase, respectively, both intracellularly and extracellularly to maintain iron homeostasis [3, 28] . Once in the cell, ferrous iron can be labile or stored in ferritin after being catalyzed to ferric acid by the ferroxidase on the H chain of ferritin to reduce the damaging hydroxyl radical [3, 27] . Insulin, oxidative stress, and low antioxidant levels can regulate the iron levels through redistribution of the transferrin receptor and an increase in ferritin levels [3, 5] . In this study, by using Prussian blue staining that mainly stained ferritin-related protein complexes, we thought that ferritin, as an iron storage protein, would indicate iron storage levels in the human ovary. Though both ferrous and ferric iron can be released from ferritin, in this study by in vitro experiments that ferrous but not ferric iron has a high impact through suppression of granulosa cell proliferation, directly suppressing ovarian granulosa cell proliferation and arresting the cell cycle at G2/M phase by regulating the ROS-mediated p38 MAPK/p53/p21 pathway. These findings support the previous clinical observations that iron may affect female gonadal function. There have been several clinical studies which demonstrated that an inverse association exists between circulating iron/ferritin levels and ovarian function using several surrogate markers, such as peripheral AMH levels, and ultrasound-measured ovarian volumes (sizes) and/or antral follicle count [9, 15] . These studies [9, 15, 26] imply that iron exerts harmful effects on the gonads. However, there is a lack of evidence to substantiate the association between iron and ovarian granulosa cell function. In this study, we substantiated the negative effect of iron on granulosa cell proliferation, but were not able to differentiate the heme iron and nonheme iron, which may have differential effects on ovaries. Although it has been proposed that nonheme iron might play a more important role than heme iron in the aging process of the ovaries by in an animal study [11] , the follicular ferritin and ferrous iron levels have been reported to be negatively associated with the ovarian reserve in infertile women with endometriosis [4] and beta-thalassemia major [29] , which might be considered to represent the naturally harmful effect of heme iron on the ovary. Therefore, both heme and nonheme iron could cause damage to the ovary.
Because nonluteinized human granulosa cells are rarely retrieved in adequate amounts for in vitro experiments, therefore we used primary mouse nonluteinized granulosa cells, which were obtained as described previously [19] , to investigate the effects of ferrous and ferric iron (Fe 2+ and Fe 3+ ) on ovarian granulosa cell proliferation.
Besides, the effect of iron on the ovary takes times by years and we could not simulate the duration of iron exposure due to the limitation by cell culture experiments, but instead we chose supraphysiologic dose of iron to investigate the effect of iron on the ovary. Such dose of iron treatment was found to arrest cell cycle but not increase cyto- toxic apoptosis in this study. In addition, the doses of iron treatment in this study ranged from approximately 3-to 17-fold of physiologic serum iron levels and were determined according to a previous reference [30] . In this study, we identified the signaling pathway that is associated with Fe 2+ -induced ovarian granulosa cell proliferation inhibition, as we determined that iron deposition ultimately induces p21-p53-p38 MAPK activation and cell cycle arrest. The CDK inhibitor p21 is a potent universal cell cycle inhibitor that can arrest the cell cycle at any stage, including G2/M phase [21] , and may be a target of the tumor suppressor gene p53 [31] . The PI3K, ERK, and p38 MAPK signaling pathways all regulate p53 expression; however, we found that only the p38 MAPK inhibitor could suppress Fe 2+ -induced p53 expression in granulosa cells. In addition, Fe 2+ treatment directly enhanced the expression of phosphorylated p38. Either an ROS inhibitor or a p38 MAPK inhibitor could suppress the above-mentioned increases in phosphorylated p38 expression in the setting of Fe 2+ treatment. All of these findings indicate that p38 MAPK pathway activity is affected by Fe 2+ -related ROS production and therefore affects downstream p53 and p21 expression. Iron has dual effects in the human body. Iron is essential for cellular growth, metabolism, and replication [32] . Iron accumulation has been linked to oxidative tissue damage leading to carcinogenesis [33] , and iron reduction by phlebotomy has been shown to reduce the risk of cancer in a randomized trial [34] . Iron depletion by iron chelators has been reported to lead to p38MAPK upregulation and cell cycle arrest, similar to the effects of excess Fe 2+ on granulosa cell proliferation observed in this study, but exerts equivocal effects on p53 expression [28] . Furthermore, iron depletion by iron chelators was reported to downregulate p21 protein expression but increase p21 mRNA expression via a p53-independent pathway, subsequently causing cell cycle arrest, mainly at G1/S phase, which results in apoptosis [28, 35] . However, in this study, we found that Fe 2+ -induced granulosa cell cycle arrested in G2/M phase but not in G1/S phase, such discrepancy of arrested cell cycle phase in response to the induction of p21 has been reported previously [36, 37] and might be due to different cell origins or environmental reactants [36] [37] [38] . Both iron excess and iron depletion can cause cell cycle arrest by exerting differential effects on the p21/p53/p38 MAPK signaling pathway. In our study, we demonstrated that, unlike Fe depletion, Fe 2+ overload may exert its effect on mice ovarian granulosa cells by upregulating p21 mRNA and protein expression through a p53-dependent pathway. Furthermore, we also demonstrated that iron deposition, represented by positive Prussian blue staining, was associated with increased p21 and p53 expression, increased cell cycle arrest at G2/M by increased CDC25C expression, but decreased granulosa cell proliferation and PCNA expression in large antral follicles from human ovaries.
In conclusion, our study is the first to demonstrate that iron can directly affect gonadal function by suppressing ovarian granulosa cell proliferation via regulation of the ROS-mediated p38 MAPK/p53/p21 pathway to arrest the cell cycle of granulosa cells. Such findings substantiate the potential role of iron on destroying the female gonadal function.
Supplementary data
Supplementary data are available at BIOLRE online. Table S1 . Demographic data of all enrolled subjects for Prussian blue staining of ovaries.
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